Genprex, Inc. Amortization of Intangible Assets
Genprex, Inc. (GNPX) reported Amortization of Intangible Assets of $773.48 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2025-04-01
- Genprex, Inc. amortization of intangible assets for the quarter ending 2024-12-31 was $0.00.
- Genprex, Inc. amortization of intangible assets for the quarter ending 2024-09-30 was $0.00.
- Genprex, Inc. amortization of intangible assets for the quarter ending 2023-12-31 was $0.00.
- Genprex, Inc. amortization of intangible assets for the quarter ending 2023-09-30 was $0.00.
- Genprex, Inc. amortization of intangible assets for fiscal 2024 was $773.48K.
- Genprex, Inc. amortization of intangible assets for fiscal 2023 was $0.00.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $0.00 derived: sum of 2 quarters · filed 2025-04-01 | $773.48K 10-K · filed 2025-04-01 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $773.48K 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | $773.48K 10-Q · filed 2024-08-09 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $0.00 derived: sum of 2 quarters · filed 2025-04-01 | $0.00 10-K · filed 2025-04-01 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |